| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 199-208, Copyright © 1989 by Endocrine Society
ARTICLES |
M Centrella, E Canalis, TL McCarthy, AF Stewart, JJ Orloff and KL Insogna
Department of Medicine (Endocrine Section), Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105.
Proteins with biochemical function and sequence similarity to PTH are produced by many tumors associated with hypercalcemia and may have a role in pathological bone remodeling. Synthetic polypeptides comprising the amino-terminus of human PTH-related protein (PTH-rp) were examined for effects in intact fetal rat calvariae, and in osteoblast-enriched (ob) cultures isolated from fetal rat parietal bone. In cultured calvariae, 0.5-5 nM PTH-rp stimulated [3H]thymidine incorporation into DNA by 25-70% after 24 h of treatment and decreased relative [3H]proline incorporation into collagen by 50%; the inhibitory effect on collagen production was not altered by hydroxyurea, which decreased DNA synthesis by 85%. PTH-rp also increased [3H]hydroxyproline levels by 100% in culture medium from bones prelabeled with [3H]proline, indicating accelerated matrix turnover. In contrast to results in intact calvariae, PTH-rp had little effect on basal DNA and collagen synthesis in serum-deprived ob cultures. However, when ob cultures were treated with transforming growth factor type beta at concentrations similar to those found in calvarial culture medium, 0.02-2 nM PTH-rp enhanced DNA synthesis and decreased collagen production. Furthermore, equimolar PTH-rp and PTH concentrations similarly displaced 125I-PTH-rp binding and enhanced cAMP synthesis in ob cultures. These studies suggest that PTH-rp regulates osteoblastic cell activity primarily through PTH-related pathways and may act in part by modulating the effects of locally produced transforming growth factor-beta in bone.
This article has been cited by other articles:
![]() |
W. Chang, A. Rewari, M. Centrella, and T. L. McCarthy Fos-related Antigen 2 Controls Protein Kinase A-induced CCAAT/Enhancer-binding Protein {beta} Expression in Osteoblasts J. Biol. Chem., October 8, 2004; 279(41): 42438 - 42444. [Abstract] [Full Text] [PDF] |
||||
![]() |
A H K El-Hashash and S J Kimber Trophoblast differentiation in vitro: establishment and characterisation of a serum-free culture model for murine secondary trophoblast giant cells Reproduction, July 1, 2004; 128(1): 53 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Centrella, T. L. McCarthy, W.-Z. Chang, D. C. Labaree, and R. B. Hochberg Estren (4-Estren-3{alpha},17{beta}-diol) Is a Prohormone that Regulates Both Androgenic and Estrogenic Transcriptional Effects through the Androgen Receptor Mol. Endocrinol., May 1, 2004; 18(5): 1120 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. McCarthy, W.-Z. Chang, Y. Liu, and M. Centrella Runx2 Integrates Estrogen Activity in Osteoblasts J. Biol. Chem., October 31, 2003; 278(44): 43121 - 43129. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Delany, I. Kalajzic, A. D. Bradshaw, E. H. Sage, and E. Canalis Osteonectin-Null Mutation Compromises Osteoblast Formation, Maturation, and Survival Endocrinology, June 1, 2003; 144(6): 2588 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ji, O. Eickelberg, T. L. McCarthy, and M. Centrella Control and Counter-Control of TGF-{beta} Activity through FAST and Runx (CBFa) Transcriptional Elements in Osteoblasts Endocrinology, September 1, 2001; 142(9): 3873 - 3879. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. ESBRIT, M. V. ALVAREZ-ARROYO, F. DE MIGUEL, O. MARTIN, M. E. MARTINEZ, and C. CARAMELO C-Terminal Parathyroid Hormone-Related Protein Increases Vascular Endothelial Growth Factor in Human Osteoblastic Cells J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1085 - 1092. [Abstract] [Full Text] |
||||
![]() |
T. L. McCarthy, C. Ji, Y. Chen, K. Kim, and M. Centrella Time- and Dose-Related Interactions between Glucocorticoid and Cyclic Adenosine 3',5'-Monophosphate on CCAAT/Enhancer-Binding Protein-Dependent Insulin-Like Growth Factor I Expression by Osteoblasts Endocrinology, January 1, 2000; 141(1): 127 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ji, Y. Chen, T. L. McCarthy, and M. Centrella Cloning the Promoter for Transforming Growth Factor-beta Type III Receptor. BASAL AND CONDITIONAL EXPRESSION IN FETAL RAT OSTEOBLASTS J. Biol. Chem., October 22, 1999; 274(43): 30487 - 30494. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Nowak, F. Haimovici, J. D. Biggers, and G. T. Erbach Transforming Growth Factor-ß Stimulates Mouse Blastocyst Outgrowth through a Mechanism Involving Parathyroid Hormone-Related Protein Biol Reprod, January 1, 1999; 60(1): 85 - 93. [Abstract] [Full Text] |
||||
![]() |
J. H. Shin, C. Ji, S. Casinghino, T. L. McCarthy, and M. Centrella Parathyroid Hormone-related Protein Enhances Insulin-like Growth Factor-I Expression by Fetal Rat Dermal Fibroblasts J. Biol. Chem., September 19, 1997; 272(38): 23498 - 23502. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, P. Rotwein, and M. Centrella 17beta -Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures J. Biol. Chem., July 18, 1997; 272(29): 18132 - 18139. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Thomas, Y. Umayahara, H. Shu, M. Centrella, P. Rotwein, and T. L. McCarthy Identification of the cAMP Response Element That Controls Transcriptional Activation of the Insulin-like Growth Factor-I Gene by Prostaglandin E2 in Osteoblasts J. Biol. Chem., September 6, 1996; 271(36): 21835 - 21841. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. McCarthy, S. Casinghino, D. W. Mittanck, C.-H. Ji, M. Centrella, and P. Rotwein Promoter-dependent and -independent Activation of Insulin-like Growth Factor Binding Protein-5 Gene Expression by Prostaglandin E(2) in Primary Rat Osteoblasts J. Biol. Chem., March 22, 1996; 271(12): 6666 - 6671. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. McCarthy, C. Ji, Y. Chen, K. K. Kim, M. Imagawa, Y. Ito, and M. Centrella Runt Domain Factor (Runx)-dependent Effects on CCAAT/ Enhancer-binding Protein delta Expression and Activity in Osteoblasts J. Biol. Chem., July 7, 2000; 275(28): 21746 - 21753. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |